GlassScriptPhysician profile
Marshall Quinn Coco
NPI 1013045624
$2,015.77
in general payments reported to CMS, 2019-2025
16 companies · $174 in 2025
The $174 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $345 · 2022: $641 · 2023: $510 · 2024: $346 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,031.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,030.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $484.16 | 2021-2024 | Corevalve Evolut R, Avalus, Cobalt Dr Mri Surescan |
| Silk Road Medical, INC. | $298.63 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Janssen Pharmaceuticals, INC | $240.59 | 2021-2023 | Xarelto |
| Abbott Laboratories | $169.96 | 2022-2024 | Cardiomems |
| Philips North America LLC | $169.06 | 2022-2025 | (Bs2) Lm Undivided, Lm Undivided |
| Getinge USA Sales, LLC | $143.35 | 2021 | |
| Pfizer INC. | $127.01 | 2021-2023 | |
| Novo Nordisk INC | $111.76 | 2025 | Ozempic |
| Amgen INC. | $59.94 | 2023-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $58.44 | 2022 | |
| Novartis Pharmaceuticals Corporation | $49.31 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.70 | 2022-2024 | Jardiance |
| Genentech USA, INC. | $26.03 | 2025 | Itovebi |
| Boston Scientific Corporation | $19.08 | 2023 | Rhythmia Mapping System |
| Esperion Therapeutics, INC. | $15.60 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $10.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marshall Coco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.